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BACKGROUND: Globally, nearly 3 billion people rely on solid fuels for cooking and heating, the vast majority residing in low- and middle-income
countries (LMICs). The resulting household air pollution (HAP) is a leading environmental risk factor, accounting for an estimated 1.6 million prema-
ture deaths annually. Previous interventions of cleaner stoves have often failed to reduce exposure to levels that produce meaningful health improve-
ments. There have been no multicountry field trials with liquefied petroleum gas (LPG) stoves, likely the cleanest scalable intervention.
OBJECTIVE: This paper describes the design and methods of an ongoing randomized controlled trial (RCT) of LPG stove and fuel distribution in
3,200 households in 4 LMICs (India, Guatemala, Peru, and Rwanda).
METHODS: We are enrolling 800 pregnant women at each of the 4 international research centers from households using biomass fuels. We are ran-
domly assigning households to receive LPG stoves, an 18-month supply of free LPG, and behavioral reinforcements to the control arm. The mother is
being followed along with her child until the child is 1 year old. Older adult women (40 to <80 years of age) living in the same households are also
enrolled and followed during the same period. Primary health outcomes are low birth weight, severe pneumonia incidence, stunting in the child, and
high blood pressure (BP) in the older adult woman. Secondary health outcomes are also being assessed. We are assessing stove and fuel use, conduct-
ing repeated personal and kitchen exposure assessments of fine particulate matter with aerodynamic diameter ≤2:5 lm (PM2:5), carbon monoxide
(CO), and black carbon (BC), and collecting dried blood spots (DBS) and urinary samples for biomarker analysis. Enrollment and data collection
began in May 2018 and will continue through August 2021. The trial is registered with ClinicalTrials.gov (NCT02944682).




Globally, nearly 3 billion people rely on solid fuels (wood, dung,
coal, charcoal, or agricultural crop waste) for cooking and heating
(Bonjour et al. 2013). These fuels are often burned in inefficient
and poorly ventilated combustion devices (e.g., open fires, tradi-
tional stoves). The resulting household air pollution (HAP)
accounts for an estimated 1.6 million premature deaths per year
and 59.5 million disability-adjusted life-years (GBD 2018).
Despite progress in recent years, this largely preventable expo-
sure remains a leading risk factor for morbidity and mortality
worldwide. Poor populations in low- and middle-income coun-
tries (LMICs) bear most of this burden (GBD 2018).
Several studies have documented association between HAP
and multiple diseases or health conditions including chronic lung
disease, lung cancer, cancers of the aerodigestive tract, cervical
cancer in adults, pediatric acute lower respiratory infections
(ALRI), or pneumonia, low birth weight, stillbirth, preterm birth,
childhood stunting (short length for age), tuberculosis, and
impaired cognitive development (Bruce et al. 2015; Smith et al.
2014; Gordon et al. 2014; Quansah et al. 2017; Thakur et al.
2018). However, except for pediatric ALRI, current methods
used for the global HAP-attributable disease burden calculations
are focused primarily on cardiovascular disease (CVD) and
chronic respiratory diseases in adults using integrated exposure–
response functions drawn substantially from estimates of effects
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of other sources of air pollution (Burnett et al. 2014).
Additionally, adverse birth outcomes such as low birth weight
and preterm birth, along with childhood development and growth,
are not included in the global burden of disease estimates.
Therefore, the current estimate for the burden of disease related
to HAP is uncertain and likely underestimated.
The state of the science illustrates several compelling reasons
to undertake a multicountry randomized controlled trial (RCT)
for reducing HAP using a clean fuel intervention. We will
address several knowledge gaps in this study. First, liquefied pe-
troleum gas (LPG) is currently the most widely available clean
fuel in LMICs (IEA 2017), but to date, no LPG trials have been
conducted that demonstrate significantly improved health out-
comes among children and adults. Currently available cleaner-
burning biomass combustion stoves are unlikely to achieve or
sustain health-relevant exposure reductions (Clark et al. 2013;
Bruce et al. 2015; Anenberg et al. 2013; Sambandam et al. 2015).
This trial will provide needed evidence from a randomized LPG
stove intervention to support policy formulation on national levels.
Second, focusing on a combination of child (birth weight, pneumo-
nia, and stunting) and adult cardiovascular [blood pressure (BP)]
primary outcomes is strategic for public health goals in LMICs, as
these conditions contribute the most to HAP-associated health bur-
dens in these settings (GBD 2018). Although HAP has been identi-
fied as a risk factor for these outcomes, intervention efforts
directed at birth outcomes, child health, and noncommunicable dis-
ease risk have been included in a few RCTs aimed at reducing
HAP. Furthermore, we will evaluate biomarkers and other indica-
tors that are known to predict noncommunicable disease occur-
rence and/or severity across the lifespan. Third, establishing
exposure–response relationships across a range of personal expo-
sures to HAP is needed to close critical gaps in our current under-
standing of exposure to disease relationships (Steenland et al.
2018). Exposure–response relationships are also critical for trans-
ferability of trial results across settings and for benchmarking
future intervention efforts. Finally, most stove intervention studies
have failed to adequately investigate and address the behaviors
necessary to overcome concurrent use of polluting stoves (a prac-
tice known as stacking) to ensure consistent and sustained use of
cleaner stoves and displacement of polluting ones (Rosenthal et al.
2017).
This paper summarizes the rationale, study design, and meth-
ods of the Household Air Pollution Intervention Network
(HAPIN) trial, a recently launched RCT that seeks to provide the
evidence necessary for policy makers to determine what health
benefits that can be achieved by implementing a scalable (in
many areas) intervention aimed directly at reducing HAP in
LMICs. The trial represents the first multicountry RCT to assess
the effect of a stove intervention LPG on exposure to HAP and
on a broad range of maternal, child, and adult health outcomes.
Study Aims
The study has three specific aims. The first is to determine the
effect of a randomized LPG stove and fuel intervention on health
in four diverse biomass-using LMIC populations across the world
using a common protocol. We hypothesize that compared to
pregnant women (18 to <35 years of age) in control households
(n=1,600), those who receive LPG stoves and fuel (n=1,600)
will have offspring with increased birth weight, reduced severe
pneumonia incidence, and improved growth [less stunting,
defined as length-for-age z-score less than 2 standard deviations
(SD) below the median z-score based on World Health
Organization (WHO) child growth standards] up to 12 months of
age. We also hypothesize that compared to control households,
older adult women (40 to <80 years of age) living in households
that receive LPG stoves and fuel will have reduced BP. In addi-
tion to these primary outcomes, the study will assess multiple
secondary outcomes on mothers, infants, and older adult women.
The second aim is to evaluate the exposure–response associa-
tions for HAP and health outcomes in four diverse LMIC popula-
tions. Using repeated 24-h personal and indirect measurements
of exposure to fine particulate matter with aerodynamic diame-
ter ≤2:5 lm (PM2:5), carbon monoxide (CO), and black carbon
(BC), we will characterize the exposure–response associations
for all primary and secondary outcomes (assessing potential
nonlinearity) while adjusting for confounders. While evidence
for an overall effect of the intervention will be available from
the first aim, analysis of exposure–response is critical for quan-
titative risk assessment and policy determinations of acceptable
levels of HAP regardless of the cooking technologies and/or
fuels in use.
The third aim is to evaluate the extent to which biomarkers of
exposure and health effects, including targeted and exploratory
(e.g., metabolomics) analyses, are associated with intervention sta-
tus or exposure. We hypothesize that participants residing in
households that receive LPG stoves and fuel or have lower levels
of exposure to HAP will have lower levels of carcinogenic polycy-
clic aromatic hydrocarbons and volatile organic compounds, such
as urinary 1-OH-pyrene, 2-naphthol, 9-phenanthrene, as well as of
chronic disease indicators, such as inflammatory, endothelial,
inflammatory, oxidative stress, and glycemic control/diabetes bio-
markers [e.g., C-reactive protein (CRP), endothelin-1, E-selectin,
interleukin 6, and hemoglobin A1c (HbA1c)] when compared to
participants in control households.
By comparing an LPG stove and continuous free fuel inter-
vention with standard cooking practices (typically traditional
solid biomass in these settings), the HAPIN trial will provide an
estimate of a potentially achievable level of HAP reduction and
the associated impact on select maternal, infant, and adult
health outcomes. Establishing exposure–response relationships
in LMIC settings will allow for estimates of the range of
improvement that can be expected across real-world conditions




The study is an RCT of an LPG stove and continuous fuel distri-
bution intervention and promotion of its exclusive use among
3,200 households in four LMICs (India, Guatemala, Peru, and
Rwanda). Following an 18-month period of planning, piloting,
and formative research, the study began recruiting participants in
May 2018 and is expected to complete enrollment in February
2020; follow-up data collection will continue through August
2021. In each country, eligible pregnant women are recruited and
their households randomly assigned to intervention and control
groups on a 1:1 ratio, and they are followed for ∼ 18 months until
their newborn child is 1 year old. Intervention households receive
a free LPG stove and free unlimited supply of LPG for the
18-month follow-up period. Control group households do not
receive an LPG stove and fuel during the study period, and it is
anticipated that they will continue cooking with solid biomass
fuels during the trial. After enrollment, assessments will be made
on a regular schedule over the course of the pregnancy (baseline,
24–28 wk gestation, 32–36 wk gestation), at 3 months of age,
6 months of age, and 12 months of age for the child, and at the
same time points for the older adult woman in the household
(Table 1). Control group compensation is summarized below and
described elsewhere (Quinn et al. 2019).
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Study Settings and Formative Research
The study is being conducted across four LMIC settings in which
large portions of the population use solid biomass as the primary
fuel type. To increase generalizability, the settings were purpose-
fully selected to represent a diversity of characteristics expected
to influence intervention effects, including altitude, population
density, cooking practices, baseline pollution levels, and sources
of pollution other than cooking (Table 2). Other factors that may
influence intervention effects, such as fuel types, dwelling charac-
teristics, and socioeconomic conditions, are being measured and
recorded. Within each country, candidate sites were selected after
evaluation in formative research over 12 months. The formative
research consisted of four phases: a) initial scoping to identify
potentially suitable sites and developing contextually grounded
behavior change strategies to promote intervention adoption, b)
pilot intervention to determine the HAP exposure contrast that
might be expected from the intervention, c) pilot assessment to
test trial procedures and methods, and d) respiratory rate/pulse
oximetry assessment to define context-specific tachypnea and
oxyhemoglobin saturation thresholds in the study sites.
Eligibility Criteria, Screening, and Recruitment
Study teams led by experienced local investigators work in col-
laboration with clinics and community health workers in each
country to identify candidate pregnant women. To be eligible to
participate in the study, a pregnant woman must meet the follow-
ing inclusion criteria: confirmed pregnancy (human chorionic go-
nadotropin–positive blood or urine test); 18 to <35 years of age
(confirmed by government-issued ID, whenever possible), cooks
primarily with biomass stoves, lives in the study area, 9 to
<20 wk gestation with a viable singleton pregnancy with normal
fetal heart rate confirmed by ultrasound, continued pregnancy
at the time of randomization (via self-report), and agrees to
participate with informed consent. Eligible pregnant women are
excluded if they currently smoke cigarettes or other tobacco prod-
ucts, plan to move permanently outside the study area in the next
12 months, use a clean fuel stove predominantly, or are likely to
use LPG or another clean fuel predominantly in the near future.
Ultrasound measurements are conducted by trained personnel
(who are also additionally certified centrally) in a clinic or
home setting to determine eligibility and assess fetal growth
using a portable ultrasound [Edge (Edge Ultrasound System),
Sonosite/Fujifilm Edge (FUJIFILM SonoSite Inc.)].
Across the trial locations, up to 800 older adult women 40 to
<80 years of age (confirmed by government-issued ID whenever
possible) who reside in the same households as an enrolled preg-
nant woman are being recruited (one per household), provided
they do not fall within the following exclusion criteria: currently
smoking cigarettes or other tobacco products, pregnant (via self-
report), or planning to permanently move out of current house-
hold in the next 12 months.
Baseline Surveys and Assessments; Randomization
Following recruitment and informed consent, a baseline visit is
made to the household by a trained fieldworker to conduct sur-
veys and other assessments. This baseline visit includes a survey
that covers a range of topics like cooking behaviors, household
composition, socioeconomic and demographic information, hous-
ing characteristics, and pregnancy-related information. Pregnant
women are also surveyed about their medical and gynecological
history, including medication use. Separate questionnaires assess
physical activity, dietary diversity, household food insecurity,
and household expenditures.
The baseline visit includes assessments of health, bio-
markers, and exposure for both the pregnant woman and older
adult woman. For pregnant women, a trained fieldworker or
nurse measures resting BP (model HEM-907XL; Omron®) in
Table 2. Summary of key characteristics of international research centers by country based on sampling, government information, or published studies.
Country India Guatemala Peru Rwanda
State/province(s)
District(s)










Provinces of Puno, San
Roman, Azángaro,







Altitude (m above sea level) 10–165 871–2,677 3,825 1,300–1,700
Population density (per km2) 892–1,098 233 17.6 274
Cooking practices (stoves, fuel,
location)
Traditional plastered clay/mud
stoves fueled with biomass,
with 90% cooking indoors.
Use of chimneys is
negligible.
Chimney stoves and open
fires; 97% wood use; cook-
ing mainly indoors

























Other sources of air pollution Incense, mosquito coils, etc.
(55% of households), trash
burning (38% of households)
Trash burning and seasonal
burning crop residue
(February–April)
Low ambient air pollution Minimal unless near
road or in more
urban/dense area.
Prevalence of smoking in the
home
Women rarely smoke. Other
smokers reported in 24% of
households but smoking
inside house reported in less
than 1% of households.
Women rarely smoke (<1%
ever smoked). Secondhand
smoke in 20% of homes,
but limited to 1–2 ciga-
rettes/day





Note: Data are from Guatemala: Fujisada H et al. 2012; Government of the Republic of Guatemala 2019; Johnson M et al. 2018. Peru: Pollard SL et al. 2014; Jaganath D et al. 2015;
Hollada J et al. 2017. India: Balakrishnan et al. 2013, 2018. Rwanda: National Institute of Statistics of Rwanda, 2010, 2012; unpublished data from Kirby et al. 2016; HAPIN formative
research results (unpublished). PM2:5, fine particulate matter with aerodynamic diameter ≤2:5.
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triplicate and maternal weight (seca 876/874 scales; Seca) and
height (seca 213 stadiometer; Seca) in duplicate. Among older
adult women, respiratory symptoms are assessed using the
Saint George’s Respiratory Questionnaire (SGRQ) (http://
www.healthstatus.sgul.ac.uk/sgrq), and quality-of-life meas-
ures are assessed using the Short Form 36 (SF-36) (https://
www.rand.org/health-care/surveys_tools/mos/36-item-short-form.
html). Further, carotid intima-media thickness (CIMT) and, in
Peru, only due to its exploratory nature, brachial artery reactiv-
ity testing (BART) are measured among older adult women
using the ultrasound devices described above. Common ca-
rotid artery (CCA) ultrasound will be performed as a marker of
atherosclerosis using a high-resolution linear transducer to
image the distal 1-cm CCA region (just proximal to the bifur-
cation) (Stein et al. 2008). CIMT will be obtained from end-
diastolic B-mode images as the average of the posterior wall
segments from both right and left CCAs, measured using an
automated system with an edge detection algorithm and man-
ual override capacity (100 separate dimensional measurements
are obtained from the 1-cm segment and averaged to obtain
mean and maximal CIMT values). BART will be performed
with a portable ultrasound to assess endothelial function using
a high-resolution linear transducer to image the brachial artery
(BA) above the antecubital fossa to measure rest diameter
(Corretti et al. 1995). The BA will be occluded for 5 min by a
BP cuff inflated to suprasystolic levels in the forearm; after
5 min of occlusion, the BP will be released, and the BA diame-
ter will be imaged every 30 s for 2.5 min after cuff deflation to
calculate percent BA dilation after hyperemia.
Urine samples (first morning void) and dried blood spots
(DBS) via finger prick are obtained from all participating preg-
nant women and older adult women. Finally, pregnant women
and the older adult women are monitored for 24-h personal and
household level exposure to HAP (PM2:5, CO, and BC) using the
procedures described below. Baseline data on ambient tempera-
ture and humidity in the home and primary cooking area are also
collected by the data loggers of the PM2:5 samplers, and dimen-
sions of the kitchen are measured by the surveyor.
After the baseline surveys and assessments are completed,
households are randomly assigned to intervention or control
arms, stratified by country. In India and Peru, additional stratified
randomization is used to ensure a balance between discrete geo-
graphical regions within the study area. In Rwanda and
Guatemala, the study areas are deemed homogenous so that such
further stratification is not necessary.
Intervention
The intervention consists of an LPG stove, a continuous supply
of LPG fuel delivered to the homes for 18 months, as well as edu-
cation and behavioral messages (described in future papers) to
promote safe, exclusive use of the LPG stove for cooking. Stoves
are procured in each country and vary (footprint, base, burner
size, nob position, and griddle) based on local cooking practices;
however, all include at least two burners and meet applicable
safety requirements. The intervention (stove and fuel) is provided
free of charge to all intervention households after baseline meas-
urements are conducted. On each visit to provide additional fuel
cylinders in Rwanda, Guatemala, and Peru, stove condition is
examined, any necessary repairs performed, and the weight of
LPG cylinders measured and recorded in order to help monitor
use and anticipate the need for additional refills. In India, per
national governmental regulations, the public sector oil marketing
company is responsible for stove installation, cylinder refills, and
repairs; study staff facilitate those activities for intervention par-
ticipants. The rate of LPG usage is monitored by calculating
average kilograms of LPG used per household member per day
(using data on fuel cylinder weights and the number of days
between installation and exchange of each cylinder).
Control Compensation
Control households receive compensation designed to meet three
aims. First, it must comply with applicable ethics requirements
for treatment of controls. Second, we are compensating control
participants for the burden associated with this study, with the
view of minimizing losses to follow-up. Third, we offset the eco-
nomic advantage to intervention households accorded by the pro-
vision of free stoves and fuel. While the details vary across the
four countries, compensation was designed based on a uniform
set of trial-wide principles that address the above aims, with
details informed by focus group discussions in the communities
selected for the intervention. Controls receive either an LPG
stove and a supply of fuel at the end of the trial or preferred alter-
natives of comparable value during or at the end of the trial.
Details concerning the development of the compensation strategy
are provided elsewhere (Quinn et al. 2019).
Primary Outcomes
Our primary health outcomes are birth weight, severe pneumonia
in the first 12 months of life, stunting at 12 months of age, and
BP in the older adult woman over 18 months of follow-up.
Birth weight is measured in duplicate to the nearest gram
within 24 h of birth by a trained fieldworker or nurse using a
routinely calibrated seca 334 mobile digital baby scale (Seca).
If the first two measurements differ by more than 10 g, a third
measurement is taken. Newborns are weighed naked or in a pre-
weighed blanket, typically at the health facility where infants
are delivered.
For the purposes of the HAPIN trial, a case of severe pneumo-
nia is adapted from the revised WHO classification of childhood
pneumonia (WHO 2014b) and is consistent with expert opinion
(Goodman et al. 2019; WHO 2014a). This classification includes
two independent algorithms for severe pneumonia, which we
have enriched with more objective imaging and pulse oximetry
criteria (Simkovich et al., in press). The first algorithm requires
the presence of cough and/or difficulty breathing, at least one
general danger sign, and primary end point pneumonia on either
lung ultrasound or chest radiograph imaging. Lung ultrasound is
our preferred imaging modality; however, if logistical reasons
preclude lung ultrasound, then we will consider chest radio-
graph images interpreted according to WHO methodology. The
second severe pneumonia algorithm requires the presence of
cough and/or difficulty breathing and hypoxemia, measured
noninvasively by pulse oximetry. We will define hypoxemia
based on the physiologic threshold of ≤92% for altitudes
<2,500 m above sea level and ≤86% for altitudes ≥2,500 m
above sea level.
BP is measured in the right arm of an older adult woman in
triplicate (with at least 2 min resting between repeat measure-
ments) using an automatic BP monitor (model HEM-907XL;
Omron®). The first measurement is ignored to reduce white coat
hypertension. The average of the second and third measurements
will be used for analysis. Measurements are taken after receiving
assurances that the older adult woman has not smoked, consumed
alcohol or a caffeinated beverage (coffee, tea, or cola), or cooked
using biomass in the 30 min prior to the measurement. She is
asked to sit in a chair in a quiet room for 5 min with legs
uncrossed, back supported by a chair, and arm supported by a ta-
ble prior to commencing the measurements.
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Secondary Outcomes
Secondary outcomes are maternal BP, preterm birth, fetal growth,
infant linear growth (as a continuous outcome), infant develop-
ment using the long-form version of Caregiver Reported Early
Development Instruments (CREDI) (McCoy et al. 2017), WHO
severe pneumonia among children <12months old, WHO pneu-
monia (both severe and nonsevere) confirmed by ultrasound in
Guatemala, burns, CIMT, BART (Peru only), SGRQ (respiratory
symptoms), SF-36 (quality of life), household expenditures for
fuel and healthcare, household time/activity, and chronic disease
biomarkers in the older adult woman. Detailed methods on these
outcomes will be included in the papers reporting the results.
Exposure Assessment
Two approaches to measure personal HAP exposure are used.
For pregnant women (baseline, 24–28 wk gestation, and 32–36
wk gestation) and older adult women (baseline and five additional
times during follow-up) (Table 1), exposure is measured through
instrumentation placed on the participant. Pollutants measured
include PM2:5, CO, and BC. PM2:5 concentrations are assessed
using both gravimetric and real-time methods, and the PM2:5 filters
are being assessed for BC with SootScan™ Model OT21
Transmissometers (Magee Scientific). The primary instrument for
this purpose is the Enhanced Children’s MicroPEM™ (ECM)
developed by RTI International (Johnson et al. 2020). Real-time
PM2:5 concentrations are estimated with the ECM’s nephelometer.
Real-time CO concentrations are measured personally for all preg-
nant women and older adult women (and for infants in Guatemala)
and area monitoring locations with EL-USB-300 CO monitors
(Lascar Electronics).
For infants for whom the ECM is impractical to use due to their
size or participant preference, a microenvironmental approach is
employed at 3, 6, and 12 months of age (Balakrishnan et al. 2004;
Xu et al. 2018; Zuk et al. 2007), whereby area sampling via ECMs
is used in main living/sleeping areas, including the kitchen. The
child is outfitted with a coin-sized location beacon (Roximity)
linked to receivers in these same areas to objectively assess loca-
tion. Personal exposures for the child are estimated by integrating
corresponding area concentrationswith time spent in the respective
locations along with time spent near the mother, who is instru-
mented with an ECM and receiver whenever feasible. Details of
this approach can be found in Liao et al. (2019), which presents
results from piloting the indirect assessment with proximity bea-
cons for the HAPIN trial in Guatemala.
To track changes in ambient PM2:5 concentrations and
broadly characterize potential for regional air quality impacting
participant exposure, ambient measurements are being made in at
least two locations at each international research sites (IRCs) field
site. Real-time ambient concentrations of PM2:5 are measured
using the E-Sampler (Met One Instruments) or comparable sys-
tems with an integrated 24-h filter-based measurement.
A full description of the exposure assessment procedures is
described elsewhere (Johnson et al. 2020).
Stove Use Monitoring
Stove use is monitored throughout the 18-month follow-up period
in both intervention and control households using a combination
of observations, reports, and instruments. Use of the LPG stoves
in intervention arm households is also tracked via data on the dis-
tribution and use of LPG cylinders. Additionally, all homes in the
intervention arm, and a subset of ∼ 80 homes in the control arm
of each country, are equipped with stove use monitors (SUMS),
which are temperature data loggers placed on traditional stoves
(Ruiz-Mercado et al. 2012; Pillarisetti et al. 2014). SUMS data
by household, supplemented with observations made by local
study teams, are reviewed weekly to identify any continued tradi-
tional stove usage. Where it occurs, local teams, following trial-
wide written standard operation procedures (SOPs), visit each
home to address barriers to exclusive LPG stove use that may be
responsible and reinforce behavioral messages developed in rela-
tion to local cooking needs to minimize future events. For exam-
ple, barriers related to capabilities and skills are addressed by
how-to training, whereas barriers related to motivation are tar-
geted with an appeal to emotions such as trust and security and
conscious decision-making. Barriers related to opportunity and
context are addressed with suggestions for adapting to contextual
realities. The 80 control homes per country comprise the 20%
random subsample in which additional exposure measurements
are taking place (as described above). The SUMS are Geocene
Temperature Loggers™, which attach high-temperature thermo-
couples to the various stoves used in a home.
Biomonitoring
Biomarker analyses are an integral part of the trial, drawing on
existing biomarker research and developing and validating novel
biomarkers associated with HAP exposure and health. The
Biomarker Center is based at Emory University (Emory), where
samples from three international research centers are analyzed.
Samples from India are principally analyzed at a laboratory based
in India, where extensive infrastructure and capacity already
exists, and that laboratory collaborates closely with Emory in
methods and data analysis. Using urine and DBS collected at reg-
ular intervals from the pregnant woman, older adult woman, and
child (Table 1), the Biomarker Center will: a) assess repeated
measures, including targeted biomarkers of exposure, biomarkers
of tobacco smoke exposure, biomarkers of effect that are predic-
tive of clinical outcomes, and exploratory analyses that include
metabolomics, mRNA, miRNA, and DNA methylation; b) per-
form HAP-specific biomarker development and validation; c)
create and operate a biospecimen repository; and d) create a data
set for deposit in the National Institutes of Health (NIH)
BioLINCC repository and ensure that study procedures are com-
patible with that program’s requirements for biospecimen collec-
tion, labeling, and storage. Biomarker sampling methodologies
are described in detail elsewhere (Barr et al. 2020; Hu et al.
2000; Liu et al. 2014).
Prior studies link exposure to HAP with cardiometabolic bio-
markers and metabolomic profiles as measured in DBS (Clark
et al. 2009), a method that overcomes collection, transportation,
and storage limitations of venipuncture sampling. The ability to
evaluate biomarkers of exposure in young children is an innova-
tive tool for HAP research. Biomarkers of exposure (e.g., polycy-
clic aromatic hydrocarbons, volatile organic chemicals, and
levoglucosan, a marker of wood smoke) are measured at multiple
time points in all study participants; correlations will be assessed
with measured 24-h pollutant concentrations. In the older adult
woman, measurements include a suite of biomarkers of endothe-
lial function, inflammation, oxidative stress, glycemic control/di-
abetes (HbA1c), a marker with specific relevance to lung cancer
(P53 tumor-associated antigen antibodies), and enzyme induction
(cytochrome P450). These biomarkers were chosen to inform
mechanistic pathways and/or because of their capabilities to pre-
dict future disease risk. Biomarker discovery (metabolomics and
miRNA evaluations) (Espín-Pérez et al. 2014) will be conducted
using DBS collected in a subsample of children (n  100=site)
and older adult women (n  100=site).
We are also conducting a substudy focused on cancer bio-
markers, conducted in collaboration with the National Cancer
Institute, among older adult women from the Peru and Guatemala
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research centers. These centers were chosen because early data
indicated that they have a higher percentage of households with
older women than the other sites. Among these older women,
buccal cells, oral rinse, nasal turbinate, and peripheral (venous)
blood are collected at baseline and a year later (in both interven-
tion and control arms) and analyzed to provide additional data on
the effects of biomass emission exposure on biomarkers related
to cancer. Sample size for the cancer substudy was based on
available budgetary resources and in the absence of any prior
knowledge of the effect size for change in the prevalence of
biomarkers.
Follow-Up Assessments
Each participating household is followed from enrollment until
the index child reaches his/her first birthday. The data collection
schedule during this period is summarized in Table 1.
Trial Management
The trial is led by a steering committee composed of the study’s
multiple principal investigators (MPIs), the lead investigators of
each of the international research centers, the directors of the bio-
marker core, one NIH project officer, one NIH scientific officer,
and one representative of the Bill and Melinda Gates Foundation
(BMGF). The steering committee obtains guidance on particular
areas of expertise from five study cores (behavior and economics,
exposure, clinical and imaging, biomarkers, and data manage-
ment) and two working groups (pneumonia; anthropometry and
nutrition). Day-to-day management of the trial is led by the trial
coordinating center, based at Emory. The steering committee is
supported by an external advisory committee and the pneumonia
working group by an outside expert group. A data safety monitor-
ing board (DSMB) appointed by the National Heart, Lung, and
Blood Institute (NHLBI) is responsible for safeguarding the inter-
ests of study participants, assessing the safety and efficacy of
study procedures, ensuring data quality, and monitoring the over-
all conduct of the study.
Data Management and Reporting
Field staff collect data on password-protected tablets, then upload
the data (daily) to a secure REDCap™ (research electronic data
capture) server [Health Insurance Portability and Accountability
Act (HIPAA) and Federal Information Security Management Act
(FISMA) compliant] hosted by Emory. Every day after uploads,
the tablets are refreshed, and all data are deleted from the mobile
device. Emory has a daily offsite backup on the REDCap™
server.
We also implemented algorithms for real-time data quality
checking wherever possible, which triggers an error or warning
message as the staff collect the data, even if they are offline. For
example, if a staff member enters 20 kg for a baby’s weight, the
tablet shows a warning message that the value is more than the
maximum allowed, and she/he can correct the entry.
The data management core (DMC), jointly with data manag-
ers in each country, is responsible for collecting survey and other
field data on tablet-based platforms that incorporate GIS (geo-
graphical information systems) positioning and QR readers,
allowing data collection teams to scan barcodes placed on LPG
stoves, fuel tanks, exposure monitoring equipment, and biospeci-
men collection material. The DMC developed and maintains
SOPs for all data management activities, which detail specific
elements of data storage, entry, quality, transfer, processing, and
security. The main study database is maintained in REDCap™
(for forms), LIMS™ (laboratory information management system
for laboratory data), and TRICE™ (for clinical imaging). These
systems are integrated using LabKey™.
Data reports with all relevant data and metadata for each of the
analytic aims of the study are made available regularly to members
of the study steering committee, the DSMB, and the relevant study
investigators after consultation of exact data needs. However, until
results are analyzed and reported by the DMC, investigators are
blinded to study arm assignment except for the purpose ofmonitor-
ing compliance with the intervention. Nevertheless, because of the
nature of the intervention, fieldworkers are assumed to have
knowledge of study arm assignment for data collected at the house-
hold level.
Final study data associated with HAPIN publications will be
archived by the DMC to allow data sharing as per NIH require-
ments following a registration and review process by the DMC.
The DMC will manage data requests and document those receiv-
ing data.
Protocol Standardization and Data Quality Control
Several activities have been undertaken to ensure standardization
of field protocols within and between the four countries involved
in this trial. These include the use of SOPs, step-by-step instruc-
tion sheets for each case report form (CRF), and a step-by-step
visit schedule, all of which were translated into local languages
and reviewed during in-person trainings at the field sites. In addi-
tion, during these in-person trainings, the representative of each
core or work group directly observed field teams conduct practice
visits and provided real-time feedback. Finally, field supervisors
conducted weekly direct observations of enumerators and com-
pletion of a supervisor checklist that included key procedures to
observe for each measurement, as determined by their respective
core or work group.
With specific regard to CRFs, these were labeled as “M” for
CRFs collecting information on the pregnant women, “C” for
those collecting information on the child, “H” for those collect-
ing information on the household, and “A” for those collecting
information on older adult women. While the CRF content was
translated into the local language, the CRF codes (e.g., “M10”
for the mother’s demographic information) and question num-
bers were not changed to facilitate communication. In addition,
bilingual color-coded CRFs were made available to all study
staff in order to address any ambiguity on original questions
and translations.
Data quality was monitored by each core or work group, as
they had the required content knowledge to identify issues and
propose appropriate solutions. For example, for the primary out-
comes of birth weight and stunting (length-for-age z-score), the
nutrition work group received the raw REDCap™ data download
for the CRFs containing those measurements every 2 months
from the central data management center at Emory. They then
ran a standard report analysis code to generate a standard set of
parameters established by a group of nutrition experts to assess
data quality. These included summarizing missing data; descrip-
tive statistics (mean, standard deviation, and minimum and maxi-
mum for continuous variables and prevalence of low birth weight
and stunting, which are compared to DHS estimates); flagging
outliers (defined as greater than ± 3 SD) and informing field teams
so that they can identify potential errors in recording; tracking indi-
vidual child growth trajectories and flagging children that lose
weight or get shorter as they age, as thesemay be potential errors in
recording and evaluating digit preference, the number of repeat
measurements that are identical, and the time between repeatmeas-
urements as well as the time between birth and the birth weight
measurement (should bewithin 24 h).
Environmental Health Perspectives 047008-7 128(4) April 2020
Data Analysis
Analysis of primary outcomes is described below; the analyses for
secondary outcomes will be analogous. For aims 1 and 3, compari-
sons are made between the study arms to which participants were
assigned, regardless of their actual adherence to the intended con-
dition. Two-sided tests for each primary outcome will be per-
formed separately at an a level of 0.0125 (using a conservative
Bonferroni correction, i.e., a level of 0.05/4, the number of primary
outcomes). The primary analyses will include indicator variables
to account for the stratification of random sampling with different
geographical areas in India and Peru, as well as individual sites.
Analysis for a continuous measure like birth weight, absent
confounding because of the randomization, essentially is a t-test
for mean birth weight between the two arms. For the two binary
primary outcomes, pneumonia incidence over a 1-y follow-up pe-
riod and stunting at 12 months of age, we will compare the two
groups using their relative risk and accounting for randomization
strata. BP analyses in older adult women will exclude women
who self-report the use of BP medication at baseline (anticipated
to be ∼ 5%). Repeated measurements of BP of the older adult
woman will be analyzed using a random intercept model to
examine differences in mean BP over the follow-up period, con-
trolling for baseline BP. Women who begin BP medication dur-
ing follow-up will be censored at that time in this analysis. Using
longitudinal BP measurements, we will also consider whether the
intervention is associated with the rate of change in BP changes
over time in a sensitivity analysis by examining the interaction
term between time and intervention.
In a supplemental analysis, women beginning BP medication
after enrollment will be included via the method “j” described by
Tobin et al. (2005), which is based on the assumption that treated
women have BPs that are right censored in a normal distribution,
with the censoring occurring above the level at which hyperten-
sives are typically treated.
For exposure–response analyses, the general regression model
is given by
gðE½YiÞ= b0 + b1Xi + cZi,
where Yi is the primary outcome of interest, gð Þ is the appropri-
ate link function (identity for birth weight and BP, logistic for
stunting and pneumonia), Xi is the continuous exposure of inter-
est, and Zi is the vector of confounders. Potential confounders
include, but are not limited to, age, sex, body mass index, socioe-
conomic status, tobacco use, secondhand smoke, physical activ-
ity, dietary intake, and season. These potential confounders have
been identified as being associated with exposure or outcomes in
prior studies. However, we expect that exact list of confounders
to differ by outcome. For each outcome, we determine potential
confounders using previous literature and directed acyclic graph
methods. We will determine final models by evaluating change in
effect estimates for meaningful changes. Exploration of models
will consider the consideration of possible intermediate variables
and effect modification. While we do not anticipate a great
amount of missing data, we will evaluate whether the missing
data patterns are differential between intervention and control
groups, as well as evaluate the temporal pattern using Kaplan-
Meier curves. For all analyses, we will assume missing data to be
missing at random (MAR) a priori. The MAR mechanism speci-
fies that the complete data distribution can be modeled using the
observed data.
For repeated measurements of BP, an individual-level random
intercept will be included, and baseline BP will be included in
the model. We will consider PM2:5 mass to be our primary expo-
sure measurement; we will also evaluate CO and BC in second-
ary analyses. For birth weight, a gestational exposure level will
be obtained by averaging the two or three 24-h average measure-
ments available during pregnancy. For birth weight, analyses will
be restricted to full-term births, or we will take into account ges-
tational age by using as the outcome z-scores for birth weight
adjusted for gestational age [derived from INTERGROWTH
tables (https://intergrowth21.tghn.org)]. For stunting and pneu-
monia, we will consider average gestational and average first-
year-of-life exposures (average of the 24-h measurements). For
BP, we will consider time-varying exposures (24-h averages),
available at the time of BP measurement.
Study Power
Study power for primary outcomes is given in Table 3, which
summarizes the minimal detectable difference in mean (for birth
weight and BP) and minimal detectable relative risk (for stunting
and pneumonia) associated with an 80% power and a type I error
rate a level of 0.0125, assuming a 10% attrition during follow-up.
For BP, we show power calculations for 200 older adult women
per arm, although we expect about 240 per arm, given that initial
recruitment data suggest that there will be older adult women in
about 15% of households. Table 3 shows we have good power to
detect a smaller difference than has been previously reported in
the literature.
Discussion
HAP is a leading cause of morbidity and mortality, especially
among young children in LMICs (GBD 2018). Large-scale pro-
grams have succeeded in replacing traditional stoves with
improved biomass stoves that reduce fuel consumption (Pope









Change in mean birth weight (g) r2 1,600 54 89 (−27, 204)b
Change in mean blood pressure (mm Hg) r2 200 2.58 3.7 (−0:6, 8.1)c
Relative risk for stunting p1 1,600 0.81 0.79 (0.70, 0.89)d
Relative risk for HAPIN severe pneumonia p1 1,600 0.64 0.67 (0.45, 0.98)
e
Note: For a fuller description of the literature and the choice of three of these effect estimates (birth weight, blood pressure, infant pneumonia), see Steenland et al. (2018). CI, confi-
dence interval; HAPIN, Household Air Pollution Intervention Network.
aOur key population parameters were the variance of continuous measures (r2) or the incidence rates among controls (p1) for relative risks. We took our key parameter estimates from
the previous studies listed in the last column, with the exception of the control rate for pneumonia, which was estimated from our early data from the trial (Smith et al. 2011).
bThompson et al. (2011) is a substudy of a randomized trial of improved cookstoves in Guatemala (RESPIRE) in which those using stoves were compared to those not using stoves af-
ter adjusting for confounders.
cMcCracken et al. (2007) is a study of 120 older women (>38 years of age) from the same randomized trial (RESPIRE), which adjusted for confounders.
dThis comprehensive review article of the health effects of HAP exposure by Bruce et al. (2013) is based on two observational studies for moderate stunting
[z-score<2 standard deviations ðSDÞ].
eSmith et al. (2011), from the RESPIRE randomized trial, provides the estimated relative risk (RR) of 0.67, the RR for clinician-diagnosed severe pneumonia for children under 18
months of age. Our estimated background rate of 0.09 for controls is based on our observed severe pneumonia rate in both arms (treatment and control) in the HAPIN study (using the
HAPIN severe pneumonia definition), with 20% of the child person time observed, and assuming the RESPIRE RR of 0.67 for intervention vs. controls.
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et al. 2017). However, deployment of these stoves has not gener-
ally achieved major reductions of fine PM, nor have they
achieved meaningful improvements in health (Sambandam et al.
2015). Moreover, continued use of traditional stoves, along with
improved solid fuel stoves (i.e., stacking), has reduced the poten-
tial contribution of such stoves to improved health. Systematic
reviews have linked cleaner cooking fuels with improvements in
health (Quansah et al. 2017; Thakur et al. 2018; WHO 2014c;
Pope et al. 2017; Bruce et al. 2013), but evidence is still not
strong, suffers from few well-designed studies, and varies by end
point. Intervention studies of chimney stoves or improved solid
biomass stoves have provided mixed evidence of health benefits
(Sambandam et al. 2015; McCracken et al. 2007; Thompson et al.
2011; Hartinger et al. 2013; Tielsch et al. 2016; Johnson et al.
2013; Mortimer et al. 2017; Lee et al. 2019; Alexander et al.
2018). Evidence from observational studies is moderate for birth
weight, pneumonia, and BP and still sparse for stunting. Recent
trials have shown mixed results from clean cooking fuels, includ-
ing ethanol and LPG (Alexander et al. 2018; Olopade et al. 2017;
Alexander et al. 2017). Taken together, by addressing multiple
outcomes at different ages and studying several LMIC contexts,
the HAPIN trial is well positioned to fill critical scientific gaps
with direct relevance to national policies.
This study addresses many of these gaps while also advancing
knowledge in new areas. For example, the prevalence of low birth
weight continues to be high in many LMICs, and preterm birth
remains the leading cause of death among children under 5 years
of age globally (Liu et al. 2015). While substantial literature exists
on the effect of active tobacco smoking and ambient air pollution
on low birth weight and preterm birth, few studies have examined
the effect of these in LMICs or specifically the effect of HAP expo-
sures on these outcomes (Thakur et al. 2018; Sambandam et al.
2015; Balakrishnan et al. 2013, 2018; Alexander et al. 2017; Liu
et al. 2015; Amegah et al. 2014; Wylie et al. 2014). Only three
studies have quantified the association between HAP and child de-
velopmental outcomes (Suter et al. 2018; Dix-Cooper et al. 2012;
Munroe and Gauvain 2012), and only two quantified the associa-
tion between HAP and stunting (Wylie et al. 2017; Kim et al.
2017), but none have done so using a longitudinal approach in
children under 1 years of age. Our case definition of pneumonia is
designed to balance the need for sensitivity and specificity
(Goodman et al. 2019).
Similarly, the CVD burden from HAP is estimated from inte-
grated exposure–response models (Burnett et al. 2014) that are
not informed by direct measurements. Demonstrating potential
improvements in cardiovascular biomarkers and BP through the
LPG stove intervention can provide strategic information for the
prevention of CVD itself. This is especially important for
LMICs, where the health burden from noncommunicable diseases
is increasing rapidly (WHO 2017). Finally, the inclusion of mo-
lecular biomarkers of exposure and early biological effect for a
range of chronic health end points, including cancer, fills a criti-
cal need to establish biomarker-based approaches to assess long-
term health impacts from HAP (IEA 2017; Caravedo et al. 2016).
While providing policy-relevant results, our research will
incorporate important technical and training innovations, including
expert clinical outcomes and imaging support for and training in
pulmonary (point-of-care ultrasound for severe pneumonia), non-
invasive markers of cardiovascular health (ultrasound assessment
of endothelial function and CIMT), and obstetrics–gynecology (fe-
tal growth). We will analyze targeted biomarkers of exposure, sus-
ceptibility, and effect, providing the most comprehensive analysis
of relevant biomarkers in aHAP study to date.Wewill conduct dis-
covery metabolomics and miRNA, mRNA, and DNA methylation
analyses to evaluate perturbations occurring in response to HAP
exposure to discover novel HAP biomarkers.We are implementing
comprehensive stove-use monitoring, building on previous
research (Ruiz-Mercado et al. 2012; Pillarisetti et al. 2014). These
data, in conjunction with information gained in formative research
on barriers to adoption and sustained, exclusive use of LPG stoves,
will be used to maximize adherence and will help inform efforts to
minimize stackingwhen stoves are delivered.
Our study will include a more comprehensive exposure assess-
ment of PM2:5 and CO in RCTs than has been attempted to date,
with multiple measurements, modeling of exposures, and assess-
ments of stove stacking via SUMs. We expect to be able to estimate
longer-term exposure averages, which can be used in exposure–
response analyses. We anticipate a wide range of intervention to
control and cross-cohort exposure contrasts across and within our
four countries, making exposure–response analysesmore powerful.
Moreover, our study will be the first HAP intervention trial to
be conducted in multiple country settings using a common proto-
col, collecting a rich set of data with the potential to help define
the generalizability criteria of the findings. While this efficacy
study includes elements that are unlikely to be operationalized at
scale (free fuel, purposefully selected settings with low to moder-
ate ambient pollution, and frequent behavioral reinforcement to
minimize stacking with traditional stoves), it will yield important
comparable information about the most scalable clean fuel inter-
vention across different world settings. As governments world-
wide undertake efforts to reduce reliance on solid biomass fuels,
the trial will provide data-supported evidence of the immediate
and long-term health benefits that may be achieved by expanding
access to and promoting the exclusive use of clean cooking fuels
by those relying on solid biomass.
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